|
Covered Companies
Biostar Pharmaceuticals, Inc. - BSPMThere are two ways to treat patients infected with HepB in China. Interferon, a common treatment in the US, is very expensive. Without nationwide health care, Interferon is far too expensive for the average Chinese citizen. Enter Biostar Pharmaceuticals Inc (OTC BB: BSPM)- Biostar is the only Chinese company with an SFDA (Chinese version of our FDA) approval to market an over-the-counter treatment for HepB. It runs just over $1 per day, and has been proven highly effective in clinical trials. BSPM's Xin Aoxing Oleanolic Acid Capsule is the only product on the market that treats chronic hepatitis B disease at a price most Chinese can afford.
Quote Data![]()
Business Summary![]() Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and thirteen nutrients. The Company has adopted international standards and is in the process of applying for two patents.
Disclosure![]()
Myself and my associates started accumulating this a week ago. As a group, we own about 17,000 shares, purchased in the open market, from $3.50 to nearly $4. We'll buy and sell them anytime we want, and you might view this as a conflict of interest.
Current Position as of 08/27/10: 7,500 Total Dollars Liquidated as of 08/27/10: $85,355.78 Recent News Headlines![]() RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols. |
To subscribe to our newsletter, please enter your email address below. Market Summary
|




